NCT02789189终止2 期
Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail
Sun Yat-sen University0 个研究点目标入组 60 人开始时间: 2016年6月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 发起方
- 入组人数
- 60
- 主要终点
- overall survival
研究概览
简要总结
The purpose of this single arm,phase Ⅱ clinical trail is to determine the safety and efficacy of nedaplatin combined with gemcitabine in the treatment of recurrent and metastatic nasopharyngeal carcinoma
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •biopsy proved nasopharyngeal carcinoma; stage IVc according to Union for International Cancer Control (UICC) edition VII,or recurrent disease after chemotherapy and/or radiotherapy; 18 years or older; without other malignancy; proper functioning of the major organs.
排除标准
- •allergic to nedaplatin and/or gemcitabine; female within gestation period or lactation; patients received drug of other clinical trail within 3 months.
研究组 & 干预措施
nedaplatin combined with gemcitabine
Experimental
干预措施: nedaplatin and gemcitabine (Drug)
结局指标
主要结局
overall survival
时间窗: 5 years
次要结局
未报告次要终点
研究者
Qingqing Cai
Professor
Sun Yat-sen University
相似试验
招募中
2 期
Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients With Locally Advanced or Metastatic Gallbladder CancerGallbladder Cancer UnresectableNCT06591650Fudan University33
已完成
2 期
Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder SparingBladder CancerNCT03558087Matthew Galsky76
已完成
2 期
Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal CancerFallopian Tube CancerPeritoneal CancerOvarian CancerNCT00267696Ohio State University Comprehensive Cancer Center45
已完成
不适用
PhaseII trial of Gemcitabine(G)and Platinam-doublet plus continuous maintenance Gemcitabine in untreated stage three/four squamous non-small cell lung cancer(NSCLC)on-small cell lung cancerJPRN-UMIN000011794Hiroshima University Hospital33
招募中
2 期
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic CancerResectable Pancreatic AdenocarcinomaNCT06423326Emory University36